Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A

An open-label, crossover randomized study was performed to compare the pharmacokinetics (PK) of damoctocog alfa pegol and rurioctocog alfa pegol, two recombinant factor VIII (FVIII) products indicated in patients with hemophilia A, both conjugated to polyethylene glycol to reduce clearance and exten...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ann Hematol
Main Authors: Solms, Alexander, Shah, Anita, Berntorp, Erik, Tiede, Andreas, Iorio, Alfonso, Linardi, Camila, Ahsman, Maurice, Mancuso, Maria Elisa, Zhivkov, Tihomir, Lissitchkov, Toshko
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7536163/
https://ncbi.nlm.nih.gov/pubmed/32974838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-020-04280-3
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki